LB Pharmaceuticals Expands One Penn Plaza Lease with Additional 4,634 Square Feet

Reuters11-13
LB Pharmaceuticals Expands One Penn Plaza Lease with Additional 4,634 <a href="https://laohu8.com/S/XYZ">Square</a> Feet

LB Pharmaceuticals Inc. has entered into a First Amendment of Lease with One Penn Plaza LLC, amending its existing lease agreement dated May 20, 2024. The amendment provides for the lease of an additional 4,634 rentable square feet on the 10th floor at One Penn Plaza, New York. The lease term is scheduled to expire on March 31, 2032. The landlord will endeavor to deliver the expansion premises by July 1, 2026. Upon delivery, the fixed rent for the expansion premises will be $430,962 per year for the first three years, increasing to $477,302 per year starting on the third anniversary of the commencement date. A fixed rent abatement will apply for the first 150 days following delivery, subject to the terms of the amendment.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. LB Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-279074), on November 13, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment